<DOC>
	<DOCNO>NCT00984256</DOCNO>
	<brief_summary>The purpose study determine whether Malarone ® , drug approve prevent malaria take daily , still effectively prevent malaria take weekly .</brief_summary>
	<brief_title>Weekly Dosing Malarone ® Prevention Malaria</brief_title>
	<detailed_description>In study , two group volunteer expose malaria bite infect mosquito . In one group , volunteer randomly assign one 5 arm . Each arm receive different dose Malarone® , drug know prevent malaria take daily . Each dos low maximum approve dose medicine . The group treat drug could prevent symptoms infection . After exposure , group monitor period approximately 3 month see develop symptom malaria . Any subject treat appropriate medication . Subjects group blood check regularly period presence malaria parasite . At completion study , result analyze determine whether dos Malarone might effectively prevent malaria take weekly rather daily .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<mesh_term>Atovaquone</mesh_term>
	<mesh_term>Atovaquone , proguanil drug combination</mesh_term>
	<criteria>A male nonpregnant , nonlactating female 18 50 year age ( inclusive ) time screen Free clinically significant health problem Baseline ECG enter study Available participate duration study ( approximately 4 month , include screen period ) If participant female , pregnant lactate willing use contraception prevent pregnancy BMI 19 30 History malaria travel malarious country within previous 12 month History participation study potential exposure malaria vaccination malaria occur . Planned travel malarious area study period . History malaria chemoprophylaxis within 60 day prior time study entry . Chronic use antibiotic antimalarial effect Chronic use ( defined 14 day ) immunosuppressant immunemodifying drug within six month study entry . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection Acute chronic , clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination , ECG laboratory screen test Significant unexplained anemia History sickle cell disease sickle cell trait Seropositive hepatitis B hepatitis C History splenectomy Pregnant lactate female , female intend become pregnant study Suspected know current alcohol abuse define American Psychiatric Association DSM IV History neuropsychiatric disorder ( anxiety , depression , psychosis , schizophrenia ) Chronic active illicit and/or intravenous drug use History allergy atovaquone , proguanil chloroquine History psoriasis Concurrent participation research study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Atovaquone</keyword>
	<keyword>Malarone</keyword>
	<keyword>Challenge</keyword>
</DOC>